CHMP Backs Ozanimod (Zeposia) for Multiple Sclerosis CHMP Backs Ozanimod (Zeposia) for Multiple Sclerosis

The oral immunomodulator is indicated for treatment of adults with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging features.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Alert Source Type: news